Related Experiment Videos
Vitamin E protects nerve cells from amyloid beta protein toxicity
Biochemical and Biophysical Research Communications
|July 31, 1992
Summary
Amyloid beta protein (ABP) fragments are toxic to nerve cells, but can protect against glutamate toxicity at lower doses. Vitamin E, an antioxidant, may inhibit ABP-induced cell death, suggesting therapeutic potential for Alzheimer's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Alzheimer's disease is characterized by amyloid beta protein (ABP) accumulation in plaques.
- ABP and its fragments have demonstrated cytotoxicity to cultured nerve cells.
Purpose of the Study:
- To investigate the cytotoxic effects of ABP and its fragment beta 25-35 on various cell lines.
- To explore the neuroprotective potential of beta 25-35 against glutamate toxicity.
- To examine the role of vitamin E in mitigating ABP-induced neurotoxicity.
Main Methods:
- Cell culture studies using PC12 cells and other cell lines.
- Exposure to varying concentrations of ABP and beta 25-35.
- Assessment of cell viability and protection against glutamate toxicity.
- Evaluation of vitamin E's inhibitory effects on ABP-induced cell death.
Main Results:
- ABP and beta 25-35 exhibited cytotoxicity to PC12 cells above 1 x 10(-9)M and to other cell lines at higher concentrations.
- Beta 25-35 demonstrated neuroprotective effects against glutamate toxicity in PC12 cells at concentrations between 10(-9)M and 10(-11)M.
- Vitamin E, an antioxidant, inhibited cell death induced by ABP.
Conclusions:
- ABP fragments possess dose-dependent cytotoxic and neuroprotective properties.
- Vitamin E may play a role in preventing or treating Alzheimer's disease by counteracting ABP toxicity.
- These findings offer insights into potential therapeutic strategies for Alzheimer's disease.